Videos

New CEO Discusses Osiris Therapeutics' Financial Troubles

New CEO Discusses Osiris Therapeutics' Financial Troubles

Executives present future goals.

By Alliance for Regenerative Medicine04.25.16


Presented by CEO Dwayne Montgomery and CFO Greg Law.

Osiris Therapeutics is a leader in researching, developing and marketing cellular regenerative medicine products that improve the health and lives of patients and lower overall healthcare costs. Having developed the world’s first approved stem cell drug, Osiris works to further advance the medical field. Osiris’ research and development in biotechnology focuses on innovation in regenerative medicine–including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4, a viable bone matrix, Cartiform, a viable osteochondral allograft, Grafix, a cryopreserved placental membrane, TruSkin, a viable human skin allograft and Stravix, a durable placental allograft.
Related Searches:
Suggested For You

Related Breaking News

    Loading, Please Wait..